These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 6982313)
1. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. Fumagalli G; Engel AG; Lindstrom J J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313 [TBL] [Abstract][Full Text] [Related]
2. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor. Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062 [TBL] [Abstract][Full Text] [Related]
3. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates. Hohlfeld R; Sterz R; Kalies I; Peper K; Wekerle H Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Engel AG; Fumagalli G Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808 [TBL] [Abstract][Full Text] [Related]
5. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG; Tsujihata M; Lindstrom JM; Lennon VA Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997 [TBL] [Abstract][Full Text] [Related]
6. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324 [TBL] [Abstract][Full Text] [Related]
7. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897 [TBL] [Abstract][Full Text] [Related]
8. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Engel AG; Lindstrom JM; Lambert EH; Lennon VA Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis. MartÃnez-MartÃnez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332 [TBL] [Abstract][Full Text] [Related]
11. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM; Einarson BL; Lennon VA; Seybold ME J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896 [TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E1 in experimental autoimmune myasthenia gravis. Takamori M; Ide Y Neurology; 1982 Apr; 32(4):410-3. PubMed ID: 6977729 [TBL] [Abstract][Full Text] [Related]
13. The immunopathology of acquired myasthenia gravis. Engel AG; Sahashi K; Fumagalli G Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470 [TBL] [Abstract][Full Text] [Related]
14. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis. Motomura M; Niwa M; Kataoka Y; Ootsuru I; Yoshimura T; Tsujihata M; Nagataki S Neurosci Lett; 1992 Aug; 143(1-2):139-42. PubMed ID: 1436658 [TBL] [Abstract][Full Text] [Related]
15. Ultrastructural study of neuromuscular junctions in experimental autoimmune myasthenia gravis (EAMG) in rabbits. Arizono N; Takeoka O; Hasegawa M; Yonezawa T; Yamaguchi K Acta Pathol Jpn; 1985 May; 35(3):621-9. PubMed ID: 4036600 [TBL] [Abstract][Full Text] [Related]
16. Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate. Tetsuo N; Tsujihata M; Satoh A; Yoshimura T; Nakamura T; Seto M; Nagataki S J Neurol Sci; 1995 Oct; 132(2):97-104. PubMed ID: 8543956 [TBL] [Abstract][Full Text] [Related]
17. Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravis. Yeh TM; Tami JA; Krolick KA Drug Chem Toxicol; 1992; 15(1):53-65. PubMed ID: 1555523 [TBL] [Abstract][Full Text] [Related]
18. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Engel AG; Lambert EH; Howard FM Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771 [TBL] [Abstract][Full Text] [Related]
19. Effects of epinephrine, ouabain, and insulin in experimental autoimmune myasthenia gravis. Takamori M; Mori M; Ide Y; Kasai M Neurology; 1980 Feb; 30(2):167-71. PubMed ID: 6243761 [TBL] [Abstract][Full Text] [Related]
20. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]